AI assistant
Sending…
UNITED THERAPEUTICS Corp — Director's Dealing 2021
Sep 29, 2021
30320_dirs_2021-09-29_09d2f37e-7968-498d-bea5-5165819372c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2020-07-09
Reporting Person: ROTHBLATT MARTINE A (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-10 | Common Stock | G | 3787 | — | Disposed | 658579 | Indirect |
| 2021-09-17 | Common Stock | G | 10 | — | Disposed | 130 | Direct |
| 2021-09-28 | Common Stock | G | 2050 | — | Disposed | 656529 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 166 | Indirect |
Footnotes
F1: Bona fide gift of shares to a 501(c)(3) charitable organization. Reporting person retains retain voting and investment power over the shares while held at the charitable organization.
More from UNITED THERAPEUTICS Corp
Regulatory Filings
2026
Jun 2
Earnings Release
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Mar 30
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 26